Cogent Biosciences
Price & Volume
Stats
See more52W Range | $13.78-$43.73 |
Market Cap | $5.3B |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$121.6M |
Diluted EPS | -$2.16 |
News
See moreYahoo Finance • 2 months ago
High-flyer healthcare stocks: Ten names with strong momentum, weak valuations
Yahoo Finance • 3 months ago
Cogent Bioscience (COGT) Files New Drug Application For Bezuclastinib
Yahoo Finance • 3 months ago
MEDevice Boston 2026: East Coast's Top Medical Device Conference Opens Registration for August 26-27 Event
Yahoo Finance • 3 months ago
Cogent Submits NDA To FDA For Bezuclastinib In Treating Systemic Mastocytosis
About
CEO | Mr. Andrew R. Robbins M.B.A. |
CFO | Mr. John L. Green C.A., CPA |
Address | 180 Third Avenue, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 258 |